Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer

Saved in:
Bibliographic Details
Published in:Cancer Medicine
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1872018528865878016
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Medicine
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:107618
institution FRELIP
journal_source_facet Cancer Medicine
last_indexed 2026-07-29T03:33:10.727Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_alt Un estudio de fase I/II de ibrutinib más trastuzumab en cáncer de mama metastásico HER2 positivo
Une étude de phase I/II de l'ibrutinib plus trastuzumab dans le cancer du sein métastatique HER2-positif
Um Estudo de Fase I/II de Ibrutinibe Mais Trastuzumabe em Câncer de Mama Metastático HER2-Positivo
title_auth A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_es_txt Un estudio de fase I/II de ibrutinib más trastuzumab en cáncer de mama metastásico HER2 positivo
title_fr_txt Une étude de phase I/II de l'ibrutinib plus trastuzumab dans le cancer du sein métastatique HER2-positif
title_full A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_fullStr A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_full_unstemmed A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_pt_txt Um Estudo de Fase I/II de Ibrutinibe Mais Trastuzumabe em Câncer de Mama Metastático HER2-Positivo
title_short A Phase I/II Study of Ibrutinib Plus Trastuzumab in HER2‐Positive Metastatic Breast Cancer
title_sort a phase i/ii study of ibrutinib plus trastuzumab in her2‐positive metastatic breast cancer
topic Oncology
General
Oncology
url https://onlinelibrary.wiley.com/doi/10.1002/cam4.72085?af=R